{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:48Z","timestamp":1761901668881,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.msard.2021.102779","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T23:34:11Z","timestamp":1611099251000},"page":"102779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Lanzhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohui","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danqing","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoliang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.msard.2021.102779_bib0001","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1177\/1352458516678474","article-title":"Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders","volume":"10","author":"Alexis Montcuquet","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2021.102779_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbmt.2011.06.014","article-title":"Genetic variations in the mycophenolate mofetil target enzyme are associated with acute gvhd risk after related and unrelated hematopoietic cell transplantation","volume":"18","author":"Cao","year":"2012","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"issue":"9","key":"10.1016\/j.msard.2021.102779_bib0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/FPC.0b013e32833d8cf5","article-title":"Polymorphisms in type i and ii inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil","volume":"20","author":"Gensburger","year":"2010","journal-title":"Pharmacogenetics Genomics"},{"key":"10.1016\/j.msard.2021.102779_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02066","article-title":"Low-dose mycophenolate mofetil for treatment of neuromyelitis optica spectrum disorders: a prospective multicenter study in south china","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.msard.2021.102779_bib0005","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/jamaneurol.2014.2057","article-title":"Mycophenolate mofetil in the treatment of neuromyelitis optica spectrum disorder","volume":"71","author":"Huh","year":"2014","journal-title":"Jama Neurol."},{"key":"10.1016\/j.msard.2021.102779_bib0006","first-page":"9","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","author":"Jarius","year":"2012","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2021.102779_bib0007","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1742-7843.2010.00542.x","article-title":"Correlation of impdh1 gene polymorphisms with subclinical acute rejection and mycophenolic acid exposure parameters on day 28 after renal transplantation","volume":"107","author":"Kagaya","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"14","key":"10.1016\/j.msard.2021.102779_bib0008","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1177\/1352458516687403","article-title":"Predictors of response to first-line immunosuppressive therapy in neuromyelitis optica spectrum disorders","volume":"23","author":"Kim","year":"2017","journal-title":"Mult. Scler."},{"issue":"2","key":"10.1016\/j.msard.2021.102779_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jvp.12731","article-title":"Mycophenolic acid in patients with immune-mediated inflammatory diseases: from humans to dogs","volume":"42","author":"Klotsman","year":"2019","journal-title":"J. Vet. Pharmacol. Therap."},{"key":"10.1016\/j.msard.2021.102779_bib0010","doi-asserted-by":"crossref","unstructured":"Kunchok, A., Malpas, C., Nytrova, P., Havrdova, E.K., Alroughani, R., Terzi, M., et\u00a0al. 2020. Clinical and therapeutic predictors of disease outcomes in aqp4-igg+ neuromyelitis optica spectrum disorder. Mult. Scler. Relat. Disord., 38. https:\/\/doi.org\/10.1016\/j.msard.2019.101868.","DOI":"10.1016\/j.msard.2019.101868"},{"issue":"9451","key":"10.1016\/j.msard.2021.102779_bib0011","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.msard.2021.102779_bib0012","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.bbmt.2018.04.006","article-title":"Impdh pharmacogenetics in hematopoietic cell transplantation patients","volume":"24","author":"Mccune","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.msard.2021.102779_bib0013","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamaneurol.2013.5699","article-title":"Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy","volume":"71","author":"Mealy","year":"2014","journal-title":"Jama Neurol."},{"issue":"13","key":"10.1016\/j.msard.2021.102779_bib0014","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1177\/1352458517730131","article-title":"Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders","volume":"24","author":"Mealy","year":"2017","journal-title":"Mult. Scler."},{"issue":"15","key":"10.1016\/j.msard.2021.102779_bib0016","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1212\/WNL.0000000000009245","article-title":"Evaluation of efficacy and tolerability of first-line therapies in nmosd","volume":"94","author":"Poupart","year":"2020","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2021.102779_bib0017","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00204-014-1247-1","article-title":"Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update","volume":"88","author":"Staatz","year":"2014","journal-title":"Arch. Toxicol."},{"issue":"8","key":"10.1016\/j.msard.2021.102779_bib0018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/jnnp-2017-315603","article-title":"Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response","volume":"88","author":"Stellmann","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2021.102779_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.critrevonc.2005.03.012","article-title":"Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.msard.2021.102779_bib0020","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.clpt.6100347","article-title":"Impdh1 gene polymorphisms and association with acute rejection in renal transplant patients","volume":"83","author":"Wang","year":"2008","journal-title":"Clin. Pharmacol. Therap."},{"issue":"2","key":"10.1016\/j.msard.2021.102779_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2021.102779_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-015-9635-y","article-title":"Genetic variants in micrornas predict recurrence of ischemic stroke","volume":"54","author":"Zhang","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:53:12Z","timestamp":1761900792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":21,"alternative-id":["S2211034821000456"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102779","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102779"}}